Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes

Lancet

Volumn 358, Issue 9277, 2001, Pages 210-211

  Zhou, Xiao Ping ^a   Hampel, Heather ^a   Thiele, Hannelore ^b   Gorlin, Robert J ^c   Hennekam, Raoul C M ^d   Parisi, Melissa ^e   Winter, Robin M ^f   Eng, Charis ^a,g  

^a OHIO STATE UNIVERSITY   (United States)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UNIVERSITY OF WASHINGTON   (United States)

^f GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ARTICLE; BANNAYAN RILEY RUVALCABA SYNDROME; CANCER RISK; CLINICAL FEATURE; CONGENITAL TUMOR; COWDEN SYNDROME; DISEASE ASSOCIATION; DISEASE MARKER; GENETIC ANALYSIS; GERM LINE; HUMAN; MULTIPLE CANCER; MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0035928416     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05412-5     Document Type: Article

References (5)

1. Further diagnostic thoughts about the Elephant Man
2. Proteus syndrome: Diagnostic criteria, differential diagnosis, and patient evaluation
3. Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis
4. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers
5. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase